Literature DB >> 35044581

Randomized trial of intracardiac echocardiography-guided slow pathway ablation.

Peter Kupo1, Laszlo Saghy2, Gabor Bencsik2, Maria Kohari2, Attila Makai2, Mate Vamos2, Attila Benak2, Marton Miklos2, Gabriela Raileanu2, Noemi Schvartz2, Robert Pap2.   

Abstract

PURPOSE: Radiofrequency (RF) catheter ablation of the slow pathway (SP) in atrioventricular nodal reentry tachycardia (AVNRT) is highly effective; however, it may require prolonged fluoroscopy and RF time. We postulated that visualization of the SP region with intracardiac echocardiography (ICE) could decrease ablation time, minimize radiation exposure, and facilitate SP ablation compared to the standard, fluoroscopy-guided approach.
METHODS: In our study, we randomized 91 patients undergoing electrophysiologic study and SP ablation for AVNRT into 2 groups: fluoroscopy-only (n = 48) or ICE-guided (n = 43) group. Crossover to ICE-guidance was allowed after 8 unsuccessful RF applications.
RESULTS: Mapping plus ablation time (mean ± standard deviation: 18.8 ± 16.1 min vs 11.6 ± 15.0 min, p = 0.031), fluoroscopy time (median [interquartile range]: 4.9 [2.93-8.13] min vs. 1.8 [1.2-2.8] min, p < 0.001), and total ablation time (144 [104-196] s vs. 81 [60-159] s, p = 0.001) were significantly shorter in the ICE group. ICE-guidance was associated with reduced radiation exposure (13.2 [8.2-13.4] mGy vs. 3.7 [1.5-5.8] mGy, p < 0.001). The sum of delivered RF energy (3866 [2786-5656] Ws vs. 2283 [1694-4284] Ws, p = 0.002) and number of RF applications (8 [4.25-12.75] vs. 4 [2-7], p = 0.001) were also lower with ICE-guidance. Twelve (25%) patients crossed over to the ICE-guided group. All were treated successfully thereafter with similar number, time, and cumulative energy of RF applications compared to the ICE group. No recurrence occurred during the follow-up.
CONCLUSIONS: ICE-guidance during SP ablation significantly reduces mapping and ablation time, radiation exposure, and RF delivery in comparison to fluoroscopy-only procedures. Moreover, early switching to ICE-guided ablation seems to be an optimal choice in challenging cases.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atrioventricular nodal reentrant tachycardia; Intracardiac echocardiography; Radiation exposure; Radiofrequency catheterablation; Slow pathway ablation

Mesh:

Year:  2022        PMID: 35044581     DOI: 10.1007/s10840-022-01126-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  23 in total

Review 1.  Differential diagnosis of regular, narrow-QRS tachycardias.

Authors:  Demosthenes G Katritsis; Mark E Josephson
Journal:  Heart Rhythm       Date:  2015-03-28       Impact factor: 6.343

2.  2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).

Authors:  Josep Brugada; Demosthenes G Katritsis; Elena Arbelo; Fernando Arribas; Jeroen J Bax; Carina Blomström-Lundqvist; Hugh Calkins; Domenico Corrado; Spyridon G Deftereos; Gerhard-Paul Diller; Juan J Gomez-Doblas; Bulent Gorenek; Andrew Grace; Siew Yen Ho; Juan-Carlos Kaski; Karl-Heinz Kuck; Pier David Lambiase; Frederic Sacher; Georgia Sarquella-Brugada; Piotr Suwalski; Antonio Zaza
Journal:  Eur Heart J       Date:  2020-02-01       Impact factor: 29.983

Review 3.  Potential of intracardiac ultrasonography as an adjunct for mapping and ablation.

Authors:  C Stellbrink; J Siebels; J Hebe; D Koschyk; G Haltern; K Ziegert; P Hanrath; K H Kuck
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

4.  Current management and clinical outcomes for catheter ablation of atrioventricular nodal re-entrant tachycardia.

Authors:  Jonathan Chrispin; Satish Misra; Joseph E Marine; John Rickard; Andreas Barth; Aravindan Kolandaivelu; Hiroshi Ashikaga; Harikrishna Tandri; David D Spragg; Jane Crosson; Ronald D Berger; Gordon Tomaselli; Hugh Calkins; Sunil K Sinha
Journal:  Europace       Date:  2018-04-01       Impact factor: 5.214

5.  Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction.

Authors:  W M Jackman; K J Beckman; J H McClelland; X Wang; K J Friday; C A Roman; K P Moulton; N Twidale; H A Hazlitt; M I Prior
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

6.  Koch's triangle sized up: anatomical landmarks in perspective of catheter ablation procedures.

Authors:  S Inoue; A E Becker
Journal:  Pacing Clin Electrophysiol       Date:  1998-08       Impact factor: 1.976

7.  Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia.

Authors:  Demosthenes G Katritsis; Joseph E Marine; Fernando M Contreras; Akira Fujii; Rakesh Latchamsetty; Konstantinos C Siontis; George D Katritsis; Theodoros Zografos; Roy M John; Lawrence M Epstein; Gregory F Michaud; Elad Anter; Ali Sepahpour; Edward Rowland; Alfred E Buxton; Hugh Calkins; Fred Morady; William G Stevenson; Mark E Josephson
Journal:  Circulation       Date:  2016-10-17       Impact factor: 29.690

8.  An anatomically guided approach to atrioventricular node slow pathway ablation.

Authors:  M Wathen; A Natale; K Wolfe; R Yee; D Newman; G Klein
Journal:  Am J Cardiol       Date:  1992-10-01       Impact factor: 2.778

9.  Radiofrequency catheter ablation guided by intracardiac echocardiography.

Authors:  E Chu; A P Fitzpatrick; M C Chin; K Sudhir; P G Yock; M D Lesh
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

10.  Anatomical and electrophysiological variations of Koch's triangle and the impact on the slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia: a study using 3D mapping.

Authors:  Takanori Yamaguchi; Takeshi Tsuchiya; Yasutsugu Nagamoto; Koji Miyamoto; Kenji Sadamatsu; Yoshito Tanioka; Toshiaki Kadokami; Kenta Murotani; Naohiko Takahashi
Journal:  J Interv Card Electrophysiol       Date:  2013-02-14       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.